- Works count
- 631
- Citation count
- 16,200
- H-index
- 65
- i10-index
- 248
Research interests
Publications
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
The Lancet · 2017 · 10.1016/s0140-6736(17)31266-7
HIV-associated lymphomas and gamma-herpesviruses
Blood · 2008 · 10.1182/blood-2008-09-180315
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
European Journal of Cancer · 2005 · 10.1016/j.ejca.2005.08.032
Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience
Journal of Clinical Oncology · 2003 · 10.1200/jco.2003.09.139
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
Journal of Clinical Oncology · 2001 · 10.1200/jco.2001.19.10.2638
Current projects
No projects listed.